3Dornagala F, Martin G, Bogdanowicaz P, et al. Inhibition of in- ter -leukin-lbeta-induced activatin of MEK/ERK pathwar and DNAbinding of NF-kappaB and AP-1 : potential mechanism for Diac-erein effects in osteoarthritis. Biorheology, 2006,43 (34) : 577-587.
4Bartels EM, Bliddal H,Schndorff PK,et al. Symptomatic effi cacyand safety of diacerein in the treatment of osteoarthritis:a recta-analysis of randomized placebo-controlled trials. Osteoar thritis Cartilage, 2010,18 (3):289-296.
5SharmaA, RathodR, Baliga VP. An open prospective study onpostmarketing evaluation of the efficacy and toierability of diacereinin osteo-arthritis of the knee (DOK). J Indian Med Assoc, 2008,106 (1) : 54-58.
6Toegel S,Wu SQ,Piana C, et al. Comparison between chon- droprotective effects of glucosamine, cureumin, and diaecerein inIL-lstimulated C-28/12 ehondroeytes. Osteoarthritis Carti- lage, 2008,16 (10) : 1205-1212.
7Brandt KD, Smith G,Kang SY, et al. Effects of diacerthein in anaccelerated canine model of osteoarthritis. Osteoarthritis Carti-lage,1997,5(6) :438-449.
